BioWorld

June 7, 2002

MacroGenics Acquires Eliance, Raises $12.6M In Financing

Raising $12.6 million at the same time, MacroGenics Inc. acquired Eliance Biotechnology Inc. by way of an undisclosed equity exchange and entered a deal with the University of Texas Southwestern Medical Center at Dallas, which devised technology used by Eliance. (BioWorld Today) Read More

Roche Invests $20M In Genmab In Expansion Of Antibody Alliance

Rat Retinal Embryonic Neurons Grow Back Slowly, While Adult Cells Grow At More Rapid Pace

Visit BioWorld At BIO 2002

FeRx Raises $15M To Pay For Phase II/III Trial Of MTC-DOX

Senators Seeking Compromise On Legislation To Ban Cloning

Appointments And Advancements

Other News To Note

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...